Not Tagged
Not Tagged
['bladder', 'vesper', 'mibc']
 practice changing analysis of #vesper by dr. pfister: phase 3 trial reviewing soc for cis-eligible pts with mibc treated w/ gc vs ddmvac os at 5 yrs improved with ddmvac (hr 0.71) for neoadjuvant tx over gc
#asco23 #bladdercancer 
GU Oncologist | 🇨🇦 GU & NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | @ASCO Featured Voice | @TwoOncDocs podcast